Seneca House Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Seneca House Advisors's LLY Position: Q2 2026 in Review
Seneca House Advisors increased its Eli Lilly (LLY) stake by 4.4% in Q2 2026, buying an estimated $45K and bringing the position to 1,044 shares worth $1.25M. The position accounts for 0.44% of the portfolio, ranked #42.
Seneca House Advisors first reported a position in LLY in Q1 2021 and has held it in 22 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Seneca House Advisors held 1,044 shares of Eli Lilly worth $1.25M as of Q2 2026.
- Seneca House Advisors bought 44 Eli Lilly shares in Q2 2026, an estimated $45K.
- Eli Lilly made up 0.44% of Seneca House Advisors's portfolio in Q2 2026, its #42 holding.
- Seneca House Advisors first reported a position in Eli Lilly in Q1 2021 and has held it in 22 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Seneca House Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.